Financial Ratios

ADINATH BIO-LAB LTD.

NSE : NABSE : 590088ISIN CODE : INE129D01039Industry : TradingHouse : Private
BSE0.300 (0 %)
PREV CLOSE ( ) 0.30
OPEN PRICE ( ) 0.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.30 (66729)
VOLUME 10943
TODAY'S LOW / HIGH ( )0.30 0.30
52 WK LOW / HIGH ( ) 0.30.3
NSE
This Company is not listed in NSE
Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.11-0.320.000.010.01
   CEPS(Rs)-0.11-0.310.010.010.02
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.280.390.711.331.32
   Tax Rate(%)0.70-11.6230.1052.67-0.34
Margin Ratios
   Core EBITDA Margin(%)-2966.6725.4933.8527.76
   EBIT Margin(%)0.006.4037.7112.16
   Pre Tax Margin(%)0.006.4037.7012.16
   PAT Margin (%)0.004.4817.8512.20
   Cash Profit Margin (%)0.0024.9937.8133.04
Performance Ratios
   ROA(%)-30.36-55.450.110.490.56
   ROE(%)-34.08-58.010.110.490.57
   ROCE(%)-34.32-51.970.161.040.56
   Asset Turnover(x)0.000.000.020.030.05
   Sales/Fixed Asset(x)0.000.020.150.210.36
   Working Capital/Sales(x)0.000.150.331.543.31
Efficiency Ratios
   Fixed Capital/Sales(x)60.296.824.722.81
   Receivable days4834.04405.72242.211007.28
   Inventory Days0.00460.260.000.00
   Payable days
Valuation Parameters
   PER(x)0.000.00265.0829.2325.33
   PCE(x)0.000.0047.4913.779.39
   Price/Book(x)0.000.000.420.140.14
   Yield(%)0.000.000.00
   EV/Net Sales(x)471.0111.825.113.03
   EV/Core EBITDA(x)-41.99-24.5543.918.869.17
   EV/EBIT(x)-8.74-3.50184.5513.5524.89
   EV/CE(x)3.172.310.420.140.14
   M Cap / Sales0.0011.865.213.10
Growth Ratio
   Net Sales Growth(%)-100.00-91.61-30.69-40.4534.72
   Core EBITDA Growth(%)41.57-698.27-67.664.073.24
   EBIT Growth(%)59.950.00-88.2384.6215.35
   PAT Growth(%)64.370.00-82.62-12.9018.07
   EPS Growth(%)64.370.00-82.59-13.3319.05
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.271.3311.203.963.93
   Quick Ratio(x)1.271.336.953.963.93
   Interest Cover(x)7111.723663.36
   Total Debt/Mcap(x)0.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.